摘要
对46例患者通过观察治疗前后门静脉和脾静脉血流的变化,结果表明前列腺素E1(PGE1)可使门、脾静脉的口径缩小、肝血流量减少,治疗总有效率为82.6%及80.4%,副作用少,并探讨其作用机理。
In order to evaluate the efficacy of prostaglanin E 1 in treatment of cirrhotic portal hypertension,the blood flow in portal and spleen veins before and after the treatment was observed by color Doppler.Results showed that a total efficacy of 82.6% was obtained with no obvious ADRs.Its mechanism is briefly discussed.
出处
《中国新药杂志》
CAS
CSCD
1997年第5期359-361,共3页
Chinese Journal of New Drugs